Variants in protein tyrosine kinase 2 beta, PTK2B, are thought to disrupt the normal suppression of tau phosphorylation and the effects of tauopathy, thereby adding to the pathogenesis of AD.43, 44, 45. This evidence concerns the gene PTK2B and tauopathy.